Lobbying Filing Details

Total Spending

$20,000

Activities

1

Lobbyists

2

Gov't Entities

2

Filing Information
Filing UUID:
74280332-c2ab-4272-849a-03ac78d2fecb
Type:
1T - 1st Quarter - Termination
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2026 at 6:52 PM
Income:
$20,000
Expenses:
$0
Termination Date:
February 02, 2026
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: John McManus
Registrant
THE MCMANUS GROUP

Consulting

Washington, District of Columbia
Client
ROYAL BIOLOGICS

OrthoBiologics and life science company

New Jersey, United States of America
Lobbying Activities (1)
Activity 1
Medicare/Medicaid

Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers. Issues related to skin substitute payment in 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F) Skin Substitute Access and Payment Reform Act of 2025 (H.R. 5768/S. 2561). H.R.6852 - To amend title XVIII of the Social Security Act to adjust payment for skin substitute products under the Medicare program.

Lobbyists (2)
  • JOHN MCMANUS
  • ALEX WHALEN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.